Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Erdmann

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Pharmaceutics|January 25, 2025
T14diLys/DOPE Liposomes: An Innovative Option for siRNA-Based Gene Knockdown?Sophie Meinhard, Frank Erdmann, Henrike Lucas, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2026
Oscillation-generating micromixing (FDmiX) - a new method for manufacturing of mRNA-lipid nanoparticles with scalable high-throughput productionFitore Mejzini, Frank Erdmann, Julian Kunert, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 1, 2015
Composites of malonic acid diamides and phospholipids--Impact of lipoplex stability on transfection efficiencyChristopher Janich, Christian Wölk, Frank Erdmann, et al.
Journal of Biomedical Materials Research. Part A|January 23, 2020
Study on the potential mechanism of anti-inflammatory activity of covalently immobilized hyaluronan and heparinHala AlKhoury, Adrian Hautmann, Frank Erdmann, et al.
The Journal of Biological Chemistry|October 30, 2003
Substitution in position 3 of cyclosporin A abolishes the cyclophilin-mediated gain-of-function mechanism but not immunosuppressionRia Baumgrass, Yixin Zhang, Frank Erdmann, et al.
Journal of Chemical Information and Modeling|February 5, 2014
Application of docking and QM/MM-GBSA rescoring to screen for novel Myt1 kinase inhibitorsKanin Wichapong, Alexander Rohe, Charlott Platzer, et al.
Biochemical Pharmacology|November 16, 2016
Augmented reversible photoswitching of drug-target interaction through "surface borrowing"Frank Erdmann, Weilin Lin, Charlott Platzer, et al.
The EMBO Journal|July 2, 2005
Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulinFrank Edlich, Matthias Weiwad, Frank Erdmann, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 21, 2016
Fast therapeutic DNA internalization - A high potential transfection system based on a peptide mimicking cationic lipidChristopher Janich, Shashank Reddy Pinnapireddy, Frank Erdmann, et al.
The Journal of Biological Chemistry|November 20, 2009
The novel calcineurin inhibitor CN585 has potent immunosuppressive properties in stimulated human T cellsFrank Erdmann, Matthias Weiwad, Susann Kilka, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Pharmaceutics|January 25, 2025
T14diLys/DOPE Liposomes: An Innovative Option for siRNA-Based Gene Knockdown?Sophie Meinhard, Frank Erdmann, Henrike Lucas, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2026
Oscillation-generating micromixing (FDmiX) - a new method for manufacturing of mRNA-lipid nanoparticles with scalable high-throughput productionFitore Mejzini, Frank Erdmann, Julian Kunert, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 1, 2015
Composites of malonic acid diamides and phospholipids--Impact of lipoplex stability on transfection efficiencyChristopher Janich, Christian Wölk, Frank Erdmann, et al.
Journal of Biomedical Materials Research. Part A|January 23, 2020
Study on the potential mechanism of anti-inflammatory activity of covalently immobilized hyaluronan and heparinHala AlKhoury, Adrian Hautmann, Frank Erdmann, et al.
The Journal of Biological Chemistry|October 30, 2003
Substitution in position 3 of cyclosporin A abolishes the cyclophilin-mediated gain-of-function mechanism but not immunosuppressionRia Baumgrass, Yixin Zhang, Frank Erdmann, et al.
Journal of Chemical Information and Modeling|February 5, 2014
Application of docking and QM/MM-GBSA rescoring to screen for novel Myt1 kinase inhibitorsKanin Wichapong, Alexander Rohe, Charlott Platzer, et al.
Biochemical Pharmacology|November 16, 2016
Augmented reversible photoswitching of drug-target interaction through "surface borrowing"Frank Erdmann, Weilin Lin, Charlott Platzer, et al.
The EMBO Journal|July 2, 2005
Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulinFrank Edlich, Matthias Weiwad, Frank Erdmann, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 21, 2016
Fast therapeutic DNA internalization - A high potential transfection system based on a peptide mimicking cationic lipidChristopher Janich, Shashank Reddy Pinnapireddy, Frank Erdmann, et al.
The Journal of Biological Chemistry|November 20, 2009
The novel calcineurin inhibitor CN585 has potent immunosuppressive properties in stimulated human T cellsFrank Erdmann, Matthias Weiwad, Susann Kilka, et al.
Pageof 7